128 related articles for article (PubMed ID: 33640856)
1. Cyclophilin A is a factor of antitumor defense in the early stages of tumor development.
Kalinina A; Golubeva I; Kudryavtsev I; Khromova N; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
Int Immunopharmacol; 2021 May; 94():107470. PubMed ID: 33640856
[TBL] [Abstract][Full Text] [Related]
2. Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway.
Obchoei S; Sawanyawisuth K; Wongkham C; Kasinrerk W; Yao Q; Chen C; Wongkham S
Tumour Biol; 2015 Feb; 36(2):849-59. PubMed ID: 25296734
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic Parameters of Recombinant Human Cyclophilin A in Mice.
Kalinina A; Grigorieva E; Smirnova A; Kazansky D; Khromykh L
Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):57-69. PubMed ID: 38040985
[TBL] [Abstract][Full Text] [Related]
4. Secreted cyclophilin A is non-genotoxic but acts as a tumor promoter.
Kalinina A; Tilova L; Kirsanov K; Lesovaya E; Zhidkova E; Fetisov T; Ilyinskaya G; Yakubovskaya M; Kazansky D; Khromykh L
Toxicology; 2023 Dec; 500():153675. PubMed ID: 37993081
[TBL] [Abstract][Full Text] [Related]
5. Immunoregulatory cyclophilin a improves low-dose chemotherapy with a modulation of the immune tumor microenvironment in experimental models of melanoma B16 and lymphoma EL4 in vivo.
Kalinina AA; Tilova LR; Kazansky DB; Khromykh LM
Cancer Chemother Pharmacol; 2024 Jun; ():. PubMed ID: 38913118
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Human Cyclophilin A in Combination with Adoptive T-cell Therapy Improves the Efficacy of Cancer Immunotherapy in Experimental Models in vivo.
Kalinina AA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2023 May; 88(5):590-599. PubMed ID: 37331705
[TBL] [Abstract][Full Text] [Related]
7. Preparative Production and Purification of Recombinant Human Cyclophilin A.
Kalinina AA; Kolesnikov AV; Kozyr AV; Kulikova NL; Zamkova MA; Kazansky DB; Khromykh LM
Biochemistry (Mosc); 2022 Mar; 87(3):259-268. PubMed ID: 35526853
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
[TBL] [Abstract][Full Text] [Related]
9. Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer.
Feng W; Xin Y; Xiao Y; Li W; Sun D
Dig Dis Sci; 2015 Sep; 60(9):2700-11. PubMed ID: 26008617
[TBL] [Abstract][Full Text] [Related]
10. Natural Cyclophilin A Inhibitors Suppress the Growth of Cancer Stem Cells in Non-Small Cell Lung Cancer by Disrupting Crosstalk between CypA/CD147 and EGFR.
Han JM; Kim SM; Kim HL; Cho HJ; Jung HJ
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298389
[TBL] [Abstract][Full Text] [Related]
11. Evidences of monomer, dimer and trimer of recombinant human cyclophilin A.
Zhang XC; Wang WD; Wang JS; Pan JC; Zou GL
Protein Pept Lett; 2011 Dec; 18(12):1188-93. PubMed ID: 21728990
[TBL] [Abstract][Full Text] [Related]
12. Analyses of the toxic properties of recombinant human Cyclophilin A in mice.
Kalinina A; Zamkova M; Antoshina E; Trukhanova L; Gorkova T; Kazansky D; Khromykh L
J Immunotoxicol; 2019 Dec; 16(1):182-190. PubMed ID: 31646917
[TBL] [Abstract][Full Text] [Related]
13. CD147 stimulates hepatoma cells escaping from immune surveillance of T cells by interaction with Cyclophilin A.
Ren YX; Wang SJ; Fan JH; Sun SJ; Li X; Padhiar AA; Zhang JN
Biomed Pharmacother; 2016 May; 80():289-297. PubMed ID: 27133068
[TBL] [Abstract][Full Text] [Related]
14. The Role of Recombinant Human Cyclophilin A in the Antitumor Immune Response.
Kalinina AA; Silaeva YY; Kazansky DB; Khromykh LM
Acta Naturae; 2019; 11(2):63-67. PubMed ID: 31413881
[TBL] [Abstract][Full Text] [Related]
15. PPIase independent chaperone-like function of recombinant human Cyclophilin A during arginine kinase refolding.
Zhang XC; Wang WD; Wang JS; Pan JC
FEBS Lett; 2013 Mar; 587(6):666-72. PubMed ID: 23376614
[TBL] [Abstract][Full Text] [Related]
16. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis.
Yang Y; Lu N; Zhou J; Chen ZN; Zhu P
Rheumatology (Oxford); 2008 Sep; 47(9):1299-310. PubMed ID: 18567920
[TBL] [Abstract][Full Text] [Related]
17. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
[TBL] [Abstract][Full Text] [Related]
18. Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer.
Peng L; Jiang J; Chen HN; Zhou L; Huang Z; Qin S; Jin P; Luo M; Li B; Shi J; Xie N; Deng LW; Liou YC; Nice EC; Huang C; Wei Y
Cell Rep; 2021 Nov; 37(9):110069. PubMed ID: 34852234
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic administration of fucoidan represses cancer metastasis by inhibiting vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMPs) in Lewis tumor-bearing mice.
Huang TH; Chiu YH; Chan YL; Chiu YH; Wang H; Huang KC; Li TL; Hsu KH; Wu CJ
Mar Drugs; 2015 Apr; 13(4):1882-900. PubMed ID: 25854641
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells.
Ge YS; Teng WY; Zhang CD
Chin Med J (Engl); 2009 Mar; 122(6):716-24. PubMed ID: 19323941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
